Here are relevant reports on : congenital-heart-disease-treatment-devices-market
-
US Interventional Cardiology Devices Market by Type (Stents, Balloons, Structural Heart, Angio Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration, Guidewire, Introducer Sheaths), End User (Hospitals, Cardiac Centers) - Forecast to 2031
The US interventional cardiology devices market, valued at USD 12.09 billion in 2025, stood at USD 12.82 billion in 2026 and is projected to advance at a resilient CAGR of 6.7% from 2026 to 2031, culminating in a forecasted valuation of USD 17.75 billion by the end of the period. The market is driven by the increasing number of cases of heart and blood vessel diseases, especially coronary artery disease and heart valve disorders, and the aging population.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Fiber Food Ingredients Market By Type Soluble Fiber, Insoluble Fiber, Resistant Fibres, Others) By Function (Cancer Diabetes, Gastrointestinal Health, Prebiotics, Heart Disease, Weight Management) By Geography
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Nuclear Medicine Software Market by Software (Image Management, Workflow, PACS, Dosimetry, Treatment, AI/Analytics), Application (Diagnosis, Treatment, Theranostics, Research), Disease (Onco, Neuro, Cardio), End User & Region - Global Forecast to 2030
The global nuclear medicine software market, valued at US$887.5million in 2024, stood at US$970.0 million in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2030, culminating in a forecasted valuation of US$1,491.5 million by the end of the period. This growth is mainly driven by the increasing demand for early and accurate diagnostics, as precision imaging is essential for treatment planning.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Stomach Cancer Treatment Market by Treatment, Type (Chemotherapy, Immunotherapy), Disease Indication (Gastric Cancer), Route of Administration, Drug Class (PD-1/PD-L1 inhibitors, HER2 antagonists), Distribution Channel - Global Forecast to 2027
The global stomach cancer treatment market is projected to reach USD 8 billion by 2027 from USD 4 Billion in 2022, at a CAGR of 14% during the forecast period
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Foregut Surgery Devices Market by Product (Endoscope, Hand Instrument), Procedure (Complex Esophagogastric Surgery, Per-Oral Endoscopic Myotomy), Disease (Reflex Disease, Hiatal Hernias), End User (Hospitals) - Global Forecast to 2022
The global foregut surgery devices market is expected to reach USD 699.7 Million by 2023 from USD 485.1 Million in 2018, growing at a CAGR of 7.6% from 2018 to 2023. Rising incidence and prevalence of diseases, technological advancements, rising number of foregut surgical procedure some of the major driving factors driving the growth of the global foregut surgery devices market. However, the high cost of surgery hindering the growth of this market to a certain extent.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Dermatology Devices Market Size, Growth by Type (Diagnostic Devices (Dermatoscopes, Imaging Devices), Treatment Devices (Laser, Cryotherapy, Liposuction)), Application (Skin Cancer, Acne, Psoriasis, Skin Rejuvenation, Tattoo Removal) & Region - Global Forecast to 2027
The global dermatology devices market in terms of revenue was estimated to be worth $6.2 billion in 2022 and is poised to reach $11.3 billion by 2027, growing at a CAGR of 12.7% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
Heart Valves Repair Market by Procedure Type (Heart Valve Repair (Surgical, Percutaneous, Transcatheter) & Heart Valve Replacement (Type (Mechanical Valve, Bioprosthetic Valve, Tavi) & Position (Mitral Valve, Aortic Valve)) - Global Forecast to 2020
Heart valve disease occurs when one or more heart valves fail to open and close properly. This can affect the ability of heart to pump blood. Heart valve diseases can be congenital (at birth) or acquired later in life due to age-related changes, infections, heart attacks, calcific degeneration, heart disease or damage. There are mainly two types of problems that can disrupt blood flow through the valves, namely, regurgitation (incompetence) or stenosis (narrowing). Some valve problems are minor and do not need treatment while others might require medicines, lifestyle changes, and/or surgical procedures to repair or replace the valve. If not treated, advanced heart valve disease can cause heart failure, stroke, blood clots, or death due to sudden cardiac arrest (SCA).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Ear Health Market by Product (Ear Health Devices (Diagnostic Devices, Surgical Devices, Hearing Aids, Hearing Implants, CO2 Lasers), Ear Health Supplements, Ear Infection Drug Treatment), and Region - Global Forecast to 2026
The ear health market is expected to grow from USD 1.4 billion in 2021 to USD 1.9 billion by 2026, at a compound annual growth rate (CAGR) of 6.3% during the forecast period. The prominent players Sonova Holdings AG (Switzerland), Olympus Corp. (Japan), William Demant Holdings A/S (Denmark), Cochlear Limited (Australia), Stryker Corporation (US), Johnson & Johnson (US), Novartis (Switzerland), Karl Storz GMBH & Co. KG (Germany), Medtronic Plc (Ireland), Oscar Remedies Pvt Ltd. (India), and InnerScope Hearing Technologies (US).
- Published: December 2021
- Price: $ 4950
- TOC Available:
-
Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Monitoring (ECG (Holter, ILR), COM), Rhythm Management (Defibrillators (ICD, AED), Pacemaker), Application (Heart Failure, Arrhythmias, MI), Procedure (Invasive) & Region - Global Forecast to 2029
The global cardiac monitoring & cardiac rhythm management devices market, valued at US$20.7 billion in 2023, stood at US$21.3 billion in 2024 and is projected to advance at a resilient CAGR of 4.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.4 billion by the end of the period. Market growth in the Asia Pacific can be attributed to the increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking, and rising morbidity and mortality from CVD.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Uterine Fibroid Treatment Devices Market by Technology (Ablation, Hysterectomy, Myomectomy Laparoscopy, Microwave, Cryoablation, HIFU, MRgFUS, Myolysis, Embolization), Mode of Treatment (Invasive, Minimally Invasive, Non-Invasive) - Global Forecasts to 2020
The global uterine fibroid treatment devices market is technologically diverse segment with presence of large number of players. The market offers significant growth opportunities in the next five years to major as well as new players that are aspiring to enter into this medical device segment. Over the past three years, leading players of the global uterine fibroid treatment devices market have adopted new product launches, establishing new manufacturing facilities, and strategic acquisitions as its key business strategies to ensure their positive growth in this market. As of 2014,
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
